In a patient with neurosarcoidosis who required infliximab for initially refractory symptoms but is now stable, how do you decide on the optimal time to de-escalate therapy?   

Answer from: at Academic Institution
at Duke University Medical Center
Dr. @Peters, do you prefer to first taper the dose...
at Yale University School of Medicine
I usually reduce the interval slowly over several ...
at Duke University Medical Center
Sign in or Register to read more